CIRCULATING MICRORNAS ASSOCIATED WITH DOCETAXEL-RESISTANT CASTRATION-RESISTANT PROSTATE CANCER

被引：0
|
作者：
Mahon, K. L. [1 ,2 ]
Chiam, K. [2 ]
Lee, B. Y. [2 ]
Nguyen, Q. [2 ]
Boyer, M. J. [1 ]
Stockler, M. [1 ,3 ]
Pavlakis, N. [4 ]
Marx, G. [5 ]
Mallesara, G. [6 ]
Gurney, H. [7 ]
Clark, S. [2 ]
Swarbrick, A. [2 ]
Daly, R. [8 ]
Horvath, Lisa [1 ,2 ]
机构：
[1] Chris OBrien Lifehouse, Camperdown, NSW, Australia
[2] Garvan Inst Med Res, Kinghorn Canc Ctr, Canc Res Div, Sydney, NSW, Australia
[3] NHMRC Clin Trials Ctr, Sydney, NSW, Australia
[4] Royal N Shore Hosp, Dept Med Oncol, Sydney, NSW, Australia
[5] Sydney Adventist Hosp, Northern Haematol & Oncol Grp, Sydney, NSW, Australia
[6] Calvary Mater Hosp, Newcastle, NSW, Australia
[7] Westmead Hosp, Sydney, NSW, Australia
[8] Monash Univ, Melbourne, Vic 3004, Australia
来源：
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY | 2014年 / 10卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
11
引用
收藏
页码：26 / 27
页数：2
相关论文
共 50 条
  • [31] Docetaxel with or without zoledronic acid for castration-resistant prostate cancer
    Yue Pan
    Haiyong Jin
    Wei Chen
    Zhixian Yu
    Tingyu Ye
    Yuancai Zheng
    Zhiliang Weng
    Feng Wang
    International Urology and Nephrology, 2014, 46 : 2319 - 2326
  • [32] Docetaxel with or without zoledronic acid for castration-resistant prostate cancer
    Pan, Yue
    Jin, Haiyong
    Chen, Wei
    Yu, Zhixian
    Ye, Tingyu
    Zheng, Yuancai
    Weng, Zhiliang
    Wang, Feng
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2014, 46 (12) : 2319 - 2326
  • [33] Intermittent docetaxel chemotherapy is feasible for castration-resistant prostate cancer
    Kume, Haruki
    Kawai, Taketo
    Nagata, Masayoshi
    Azuma, Takeshi
    Miyazaki, Hideyo
    Suzuki, Motofumi
    Fujimura, Tetsuya
    Nakagawa, Tohru
    Fukuhara, Hiroshi
    Homma, Yukio
    MOLECULAR AND CLINICAL ONCOLOGY, 2015, 3 (02) : 303 - 307
  • [34] Docetaxel in combination with estramustine and prednisolone for castration-resistant prostate cancer
    Kuramoto, Tomomi
    Inagaki, Takeshi
    Fujii, Reona
    Sasaki, Yumiko
    Nishizawa, Satoshi
    Nanpo, Yoshihito
    Matusmura, Nagahide
    Kohjimoto, Yasuo
    Hara, Isao
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2013, 18 (05) : 890 - 897
  • [35] Docetaxel in combination with estramustine and prednisolone for castration-resistant prostate cancer
    Tomomi Kuramoto
    Takeshi Inagaki
    Reona Fujii
    Yumiko Sasaki
    Satoshi Nishizawa
    Yoshihito Nanpo
    Nagahide Matusmura
    Yasuo Kohjimoto
    Isao Hara
    International Journal of Clinical Oncology, 2013, 18 : 890 - 897
  • [36] Management of metastatic castration-resistant prostate cancer following docetaxel
    Beuzeboc, Philippe
    Ropert, Stanislas
    Goldwasser, Francois
    Zerbib, Marc
    BULLETIN DU CANCER, 2012, 99 : S66 - S72
  • [37] Exosomal microRNAs as Potential Biomarkers in Castration-resistant Prostate Cancer
    Haflidadottir, Benedikta S.
    Ceder, Yvonne
    EUROPEAN UROLOGY, 2015, 67 (01) : 42 - 43
  • [38] BIOINFORMATIC ANALYSIS UTILIZING THE ANDROGENIC SUPPRESSIVE EFFECT IDENTIFIED PROMISING CANDIDATE DRUGS FOR REPROGRAMMING DOCETAXEL-RESISTANT CASTRATION-RESISTANT PROSTATE CANCER
    Hongo, Hiroshi
    Kosaka, Takeo
    Yasumizu, Yota
    Miyazaki, Yasumasa
    Kikuchi, Eiji
    Miyajima, Akira
    Oya, Mototsugu
    JOURNAL OF UROLOGY, 2016, 195 (04): : E1097 - E1097
  • [39] DIETHYLSTILBESTROL IN CASTRATION-RESISTANT PROSTATE CANCER OESTROGENS IN CASTRATION-RESISTANT PROSTATE CANCER: BACK TO THE FUTURE?
    Sartor, Oliver
    BJU INTERNATIONAL, 2012, 110 (11B) : E736 - E736
  • [40] Circulating Tumor Cells in Metastatic Castration-Resistant Prostate Cancer
    Rini, Brian I.
    CURRENT ONCOLOGY REPORTS, 2009, 11 (03) : 163 - 164
12345